J.P. Marvel Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.2M | Buy |
80,375
+42
| +0.1% | +$9.04K | 2.32% | 12 |
|
|
2026
Q1 | $17.5M | Buy |
80,333
+2
| +0% | +$444 | 2.48% | 12 |
|
|
2025
Q4 | $18.4M | Sell |
80,331
-5,000
| -6% | -$1.14M | 2.55% | 13 |
|
|
2025
Q3 | $19.8M | Buy |
85,331
+392
| +0.5% | +$79.8K | 2.87% | 12 |
|
|
2025
Q2 | $15.8M | Sell |
84,939
-55
| -0.1% | -$10.2K | 2.54% | 11 |
|
|
2025
Q1 | $17.8M | Sell |
84,994
-95
| -0.1% | -$18.5K | 3.08% | 10 |
|
|
2024
Q4 | $15.1M | Sell |
85,089
-582
| -0.7% | -$107K | 2.5% | 11 |
|
|
2024
Q3 | $16.9M | Buy |
85,671
+411
| +0.5% | +$76.7K | 2.76% | 11 |
|
|
2024
Q2 | $14.6M | Sell |
85,260
-113
| -0.1% | -$18.7K | 2.4% | 12 |
|
|
2024
Q1 | $15.5M | Sell |
85,373
-7
| -0% | -$1.21K | 2.69% | 12 |
|
|
2023
Q4 | $13.2M | Sell |
85,380
-50
| -0.1% | -$7.29K | 2.62% | 11 |
|
|
2023
Q3 | $12.7M | Hold |
85,430
| – | – | 2.74% | 11 |
|
|
2023
Q2 | $11.5M | Sell |
85,430
-460
| -0.5% | -$67.5K | 2.4% | 11 |
|
|
2023
Q1 | $13.7M | Hold |
85,890
| – | – | 3.09% | 10 |
|
|
2022
Q4 | $13.9M | Sell |
85,890
-149
| -0.2% | -$22.8K | 3.26% | 7 |
|
|
2022
Q3 | $11.5M | Sell |
86,039
-61
| -0.1% | -$8.75K | 2.94% | 10 |
|
|
2022
Q2 | $13.2M | Hold |
86,100
| – | – | 3.17% | 9 |
|
|
2022
Q1 | $14M | Buy |
86,100
+95
| +0.1% | +$13.8K | 2.84% | 10 |
|
|
2021
Q4 | $11.6M | Buy |
+86,005
| New | +$10.2M | 2.28% | 19 |
|
|
2021
Q3 | – | Sell |
-78,088
| Closed | -$8.8M | – | 59 |
|
|
2021
Q2 | $8.8M | Buy |
78,088
+33
| +0% | +$3.72K | 1.87% | 22 |
|
|
2021
Q1 | $8.45M | Buy |
78,055
+25
| +0% | +$2.67K | 2% | 23 |
|
|
2020
Q4 | $8.36M | Buy |
78,030
+650
| +0.8% | +$62.5K | 2.16% | 16 |
|
|
2020
Q3 | $6.78M | Buy |
77,380
+150
| +0.2% | +$14.1K | 1.95% | 21 |
|
|
2020
Q2 | $7.58M | Buy |
77,230
+1,302
| +2% | +$115K | 2.4% | 16 |
|
|
2020
Q1 | $5.79M | Buy |
75,928
+330
| +0.4% | +$28.1K | 2.19% | 20 |
|
|
2019
Q4 | $6.69M | Buy |
75,598
+5
| +0% | +$415 | 1.93% | 19 |
|
|
2019
Q3 | $5.72M | Buy |
+75,593
| New | +$5.18M | 1.83% | 22 |
|
|
2019
Q1 | $6.17M | Sell |
76,554
-150
| -0.2% | -$12.3K | 2% | 18 |
|
|
2018
Q4 | $7.07M | Buy |
+76,704
| New | +$6.75M | 2.55% | 13 |
|
|
2018
Q2 | $7.16M | Sell |
77,304
-561
| -0.7% | -$54.8K | 2.19% | 17 |
|
|
2018
Q1 | $7.37M | Sell |
77,865
-560
| -0.7% | -$61.5K | 2.28% | 16 |
|
|
2017
Q4 | $7.58M | Buy |
78,425
+506
| +0.6% | +$47.7K | 2.31% | 16 |
|
|
2017
Q3 | $6.92M | Buy |
77,919
+166
| +0.2% | +$12.6K | 2.2% | 17 |
|
|
2017
Q2 | $5.64M | Hold |
77,753
| – | – | 1.86% | 20 |
|
|
2017
Q1 | $5.07M | Sell |
77,753
-3,985
| -5% | -$251K | 1.68% | 22 |
|
|
2016
Q4 | $5.12M | Hold |
81,738
| – | – | 1.75% | 23 |
|
|
2016
Q3 | $5.16M | Sell |
81,738
-770
| -0.9% | -$49.8K | 1.83% | 23 |
|
|
2016
Q2 | $5.11M | Sell |
82,508
-1,231
| -1% | -$75K | 1.79% | 23 |
|
|
2016
Q1 | $4.78M | Sell |
83,739
-354
| -0.4% | -$19.7K | 1.72% | 25 |
|
|
2015
Q4 | $4.98M | Buy |
+84,093
| New | +$4.84M | 1.73% | 23 |
|
|
2015
Q2 | $5.65M | Sell |
84,093
-2,070
| -2% | -$135K | 1.9% | 21 |
|
|
2015
Q1 | $5.04M | Sell |
86,163
-1,190
| -1% | -$71.9K | 1.72% | 23 |
|
|
2014
Q4 | $5.72M | Buy |
87,353
+31,180
| +56% | +$1.97M | 1.99% | 18 |
|
|
2014
Q3 | $3.25M | Hold |
56,173
| – | – | 1.17% | 35 |
|
|
2014
Q2 | $3.17M | Buy |
56,173
+1,720
| +3% | +$90.2K | 1.08% | 41 |
|
|
2014
Q1 | $2.8M | Buy |
54,453
+7,500
| +16% | +$379K | 0.99% | 44 |
|
|
2013
Q4 | $2.48M | Buy |
46,953
+1,500
| +3% | +$73.7K | 0.89% | 47 |
|
|
2013
Q3 | $2.03M | Hold |
45,453
| – | – | 0.79% | 49 |
|
|
2013
Q2 | $1.88M | Buy |
+45,453
| New | +$1.99M | 0.78% | 48 |
|
Other funds holding ABBV
J.P. Marvel Investment Advisors's ABBV Position: Q2 2026 in Review
J.P. Marvel Investment Advisors increased its AbbVie (ABBV) stake by 0.05% in Q2 2026, buying an estimated $9.04K and bringing the position to 80,375 shares worth $20.2M. The position accounts for 2.32% of the portfolio, ranked #12.
J.P. Marvel Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- J.P. Marvel Investment Advisors held 80,375 shares of AbbVie worth $20.2M as of Q2 2026.
- J.P. Marvel Investment Advisors bought 42 AbbVie shares in Q2 2026, an estimated $9.04K.
- AbbVie made up 2.32% of J.P. Marvel Investment Advisors's portfolio in Q2 2026, its #12 holding.
- J.P. Marvel Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on J.P. Marvel Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.